Cargando…

Age-dependent phenotypic modulation of smooth muscle cells in the normal ascending aorta

OBJECTIVES: Ascending aortic aneurysms are associated with pre-existing conditions, including connective tissue disorders (i.e., Marfan syndrome) and bicuspid aortic valves. The underlying mechanisms remain uncertain. Even less is known regarding ascending aortic aneurysms in individuals with normal...

Descripción completa

Detalles Bibliográficos
Autores principales: Balint, Brittany, Bernstorff, Inés García Lascurain, Schwab, Tanja, Schäfers, Hans-Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989028/
https://www.ncbi.nlm.nih.gov/pubmed/36895832
http://dx.doi.org/10.3389/fcvm.2023.1114355
_version_ 1784901696565018624
author Balint, Brittany
Bernstorff, Inés García Lascurain
Schwab, Tanja
Schäfers, Hans-Joachim
author_facet Balint, Brittany
Bernstorff, Inés García Lascurain
Schwab, Tanja
Schäfers, Hans-Joachim
author_sort Balint, Brittany
collection PubMed
description OBJECTIVES: Ascending aortic aneurysms are associated with pre-existing conditions, including connective tissue disorders (i.e., Marfan syndrome) and bicuspid aortic valves. The underlying mechanisms remain uncertain. Even less is known regarding ascending aortic aneurysms in individuals with normal (i.e., tricuspid) aortic valves (TAV), and without known aneurysm-associated disorders. Regardless of etiology, the risk of aortic complications increases with biological age. Phenotypic modulation of smooth muscle cells (SMCs) is a feature of ascending aortic aneurysms, whereby contractile SMCs are replaced with synthetic SMCs that are capable of degrading the aortic wall. We asked whether age itself causes dysfunctional SMC phenotype modulation, independent of aortic dilatation or pre-existing aneurysm-associated diseases. METHODS: Non-dilated ascending aortic samples were obtained intra-operatively from 40 patients undergoing aortic valve surgery (range: 20–82 years old, mean: 59.1 ± 15.2). Patients with known genetic diseases or aortic valve malformations were excluded. Tissue was divided, and a portion was formalin-fixed and immunolabeled for alpha-smooth muscle actin (ASMA), a contractile SMC protein, and markers of synthetic (vimentin) or senescent (p16/p21) SMCs. Another fragment was used for SMC isolation (n = 10). Cultured SMCs were fixed at cell passage 2 and stained for phenotype markers, or were cultured indefinitely to determine replicative capacity. RESULTS: In whole tissue, ASMA decreased (R(2) = 0.47, P < 0.0001), while vimentin increased (R(2) = 0.33, P = 0.02) with age. In cultured SMCs, ASMA decreased (R(2) = 0.35, P = 0.03) and vimentin increased (R(2) = 0.25, P = 0.04) with age. p16 (R(2) = 0.34, P = 0.02) and p21 (R(2) = 0.29, P = 0.007) also increased with age in SMCs. Furthermore, the replicative capacity of SMCs from older patients was decreased compared to that of younger patients (P = 0.03). CONCLUSION: By investigating non-dilated aortic samples from individuals with normal TAVs, we found that age itself has a negative impact on SMCs in the ascending aortic wall, whereby SMCs switched from the contractile phenotype to maladaptive synthetic or senescent states with increased age. Therefore, based on our findings, modification of SMC phenotype should be studied as a therapeutic consideration against aneurysms in the future, regardless of etiology.
format Online
Article
Text
id pubmed-9989028
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99890282023-03-08 Age-dependent phenotypic modulation of smooth muscle cells in the normal ascending aorta Balint, Brittany Bernstorff, Inés García Lascurain Schwab, Tanja Schäfers, Hans-Joachim Front Cardiovasc Med Cardiovascular Medicine OBJECTIVES: Ascending aortic aneurysms are associated with pre-existing conditions, including connective tissue disorders (i.e., Marfan syndrome) and bicuspid aortic valves. The underlying mechanisms remain uncertain. Even less is known regarding ascending aortic aneurysms in individuals with normal (i.e., tricuspid) aortic valves (TAV), and without known aneurysm-associated disorders. Regardless of etiology, the risk of aortic complications increases with biological age. Phenotypic modulation of smooth muscle cells (SMCs) is a feature of ascending aortic aneurysms, whereby contractile SMCs are replaced with synthetic SMCs that are capable of degrading the aortic wall. We asked whether age itself causes dysfunctional SMC phenotype modulation, independent of aortic dilatation or pre-existing aneurysm-associated diseases. METHODS: Non-dilated ascending aortic samples were obtained intra-operatively from 40 patients undergoing aortic valve surgery (range: 20–82 years old, mean: 59.1 ± 15.2). Patients with known genetic diseases or aortic valve malformations were excluded. Tissue was divided, and a portion was formalin-fixed and immunolabeled for alpha-smooth muscle actin (ASMA), a contractile SMC protein, and markers of synthetic (vimentin) or senescent (p16/p21) SMCs. Another fragment was used for SMC isolation (n = 10). Cultured SMCs were fixed at cell passage 2 and stained for phenotype markers, or were cultured indefinitely to determine replicative capacity. RESULTS: In whole tissue, ASMA decreased (R(2) = 0.47, P < 0.0001), while vimentin increased (R(2) = 0.33, P = 0.02) with age. In cultured SMCs, ASMA decreased (R(2) = 0.35, P = 0.03) and vimentin increased (R(2) = 0.25, P = 0.04) with age. p16 (R(2) = 0.34, P = 0.02) and p21 (R(2) = 0.29, P = 0.007) also increased with age in SMCs. Furthermore, the replicative capacity of SMCs from older patients was decreased compared to that of younger patients (P = 0.03). CONCLUSION: By investigating non-dilated aortic samples from individuals with normal TAVs, we found that age itself has a negative impact on SMCs in the ascending aortic wall, whereby SMCs switched from the contractile phenotype to maladaptive synthetic or senescent states with increased age. Therefore, based on our findings, modification of SMC phenotype should be studied as a therapeutic consideration against aneurysms in the future, regardless of etiology. Frontiers Media S.A. 2023-02-21 /pmc/articles/PMC9989028/ /pubmed/36895832 http://dx.doi.org/10.3389/fcvm.2023.1114355 Text en Copyright © 2023 Balint, Bernstorff, Schwab and Schäfers. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Balint, Brittany
Bernstorff, Inés García Lascurain
Schwab, Tanja
Schäfers, Hans-Joachim
Age-dependent phenotypic modulation of smooth muscle cells in the normal ascending aorta
title Age-dependent phenotypic modulation of smooth muscle cells in the normal ascending aorta
title_full Age-dependent phenotypic modulation of smooth muscle cells in the normal ascending aorta
title_fullStr Age-dependent phenotypic modulation of smooth muscle cells in the normal ascending aorta
title_full_unstemmed Age-dependent phenotypic modulation of smooth muscle cells in the normal ascending aorta
title_short Age-dependent phenotypic modulation of smooth muscle cells in the normal ascending aorta
title_sort age-dependent phenotypic modulation of smooth muscle cells in the normal ascending aorta
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989028/
https://www.ncbi.nlm.nih.gov/pubmed/36895832
http://dx.doi.org/10.3389/fcvm.2023.1114355
work_keys_str_mv AT balintbrittany agedependentphenotypicmodulationofsmoothmusclecellsinthenormalascendingaorta
AT bernstorffinesgarcialascurain agedependentphenotypicmodulationofsmoothmusclecellsinthenormalascendingaorta
AT schwabtanja agedependentphenotypicmodulationofsmoothmusclecellsinthenormalascendingaorta
AT schafershansjoachim agedependentphenotypicmodulationofsmoothmusclecellsinthenormalascendingaorta